Biostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan(TM) Esophageal Implant

HOLLISTON, Mass., March 20, 2020 -- (Healthcare Sales & Marketing Network) -- Biostage, Inc. (OTCQB: BSTG) (Biostage or the Company), a bioengineering company developing next-generation esophageal implants, today announced that the U.S. Food and Drug Admi... Devices, Regenerative Medicine, FDA Biostage , esophageal implant, Cellspan Esophageal Implant, Esophageal Atresia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news